Skip to main content

Advertisement

SpringerLink
Log in

Usefulness of Prophylactic Percutaneous Gastrostomy Placement in Patients with Head and Neck Cancer Treated with Chemoradiotherapy

  • Original Article
  • Published:
Dysphagia Aims and scope Submit manuscript

Abstract

Chemoradiotherapy (CRT) has evolved as the preferred organ preservation strategy in the treatment of locally advanced head and neck cancer (HNC). This approach increases malnutrition, and thus, establishing a direct enteral feeding route is essential. To evaluate the usefulness of prophylactic percutaneous endoscopic gastrostomy (PEG) in HNC patients receiving definitive CRT, we performed a prospective evaluation of HNC patients over a 6-month period. Patients and tumor characteristics, nutritional status 30 days after PEG insertion and technique complications were evaluated. We also assessed the long-term PEG usage. Forty-seven PEGs were placed and only 2 patients did not use it. The mean time of PEG use was 131 days (4–255) and mean duration of exclusive utilization was 71 days (4–180). On 30th day after procedure, 34/45 (76 %) patients had lost weight, but only 10/45 (22 %) patients had lost more than 10 % of their initial weight. The most frequent complications were minor peristomal infections, which were correlated with proton-pump inhibitor use before PEG placement (OR 3.91, 95 % CI 1.01–15.2, and p = 0.049). One year later, 19 % of patients in remission continue needing PEG. Enteric nutritional support is essential during and after CRT in HNC patients. Most patients lost weight even with PEG. One-fifth of patients in remission required long-term PEG utilization.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Devlin J, Sherman E. Combined modality treatment of squamous cell cancer of the head and neck. Clin Adv Hematol Oncol. 2005;3(5):373–82.

    PubMed  Google Scholar 

  2. Chan A, Grégoire V, Lefebvre JL, Licitra L, Hui EP, Leung SF, Felip E. Nasopharyngeal cancer: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl. 7):vii83–5.

    PubMed  Google Scholar 

  3. Marcy PY, Magné N, Bensadoun RJ, et al. Systematic percutaneous fluoroscopy gastrostomy for concomitant radiochemotherapy of advanced head and neck cancer; optimisation of therapy. Support Care Cancer. 2000;8:410–3.

    Article  CAS  PubMed  Google Scholar 

  4. Murphy B, Gilbert J. Dysphagia in head and neck cancer patients treated with radiation: assessment, sequelae and rehabilitation. Semin Radiat Oncol. 2009;19(1):35–42.

    Article  PubMed  Google Scholar 

  5. Cheng S, Terrell J, Bradford CR, et al. Variables associated with feeding tube placement in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006;132(6):655–61.

    Article  PubMed  Google Scholar 

  6. Nugent B, Lewis S, O’Sullivan JM. Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy. Cochrane Database Syst. 2010;17(3):CD007909.

    Google Scholar 

  7. Wang J, Liu M, Liu C, Ye Y, Huang G. Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for patients with head and neck cancer: a systematic review. J Radiat Res. 2014;55(3):559–67.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Ponsky J, Gauderer M. Percutaneous endoscopic gastrostomy: a nonoperative technique for feeding gastrostomy. Gastrointest Endosc. 1981;27(1):9–11.

    Article  CAS  PubMed  Google Scholar 

  9. Cravo M, Glória L, Claro I. Metabolic responses to tumour disease and progression: tumour-host interaction. Clin Nutr. 2000;19(6):459–65.

    Article  CAS  PubMed  Google Scholar 

  10. Forastiere A, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091–8.

    Article  CAS  PubMed  Google Scholar 

  11. Pignon J, Maitre A, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomized trials and 17,346 patients. Radiother Oncol. 2009;92:4–14.

    Article  PubMed  Google Scholar 

  12. Capuano G, Grosso A, Gentile PC, et al. Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head Neck. 2008;30:503–8.

    Article  PubMed  Google Scholar 

  13. Berg MG, Rasmussen-Conrad E, Nispen L, Binsbergen JJ, Merkx MA. A prospective study on malnutrition and quality of life in patients with head and neck cancer. Oral Oncol. 2008;44(9):830–7.

    Article  PubMed  Google Scholar 

  14. Bokhorst S, Leeuwen P, Leeuwen PA, et al. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer. 1999;86(3):519–27.

    Article  Google Scholar 

  15. Piquet M, Ozsahin M, Larpin I, et al. Early nutritional intervention in oropharyngeal cancer patients undergoing radiotherapy. Support Care Cancer. 2002;10(6):502–4.

    Article  PubMed  Google Scholar 

  16. Mohammad M, Blankenship M, Blankenship DM, Krempl GA, Tierney WM. Prophylactic PEG placement in head and neck cancer: how many feeding tubes are unused (and unnecessary)? World J Gastroenterol. 2011;17(8):1004–8.

    Article  Google Scholar 

  17. Wermker K, Jung S, Hüppmeier L, Joos U, Kleinheinz J. Prediction model for early percutaneous endoscopic gastrostomy (PEG) in head and neck cancer treatment. Oral Oncol. 2012;48(4):355–60.

    Article  CAS  PubMed  Google Scholar 

  18. Munshi A, Pandey M, Durga T, Pandey KC, Bahadur S, Mohanti BK. Weight loss during radiotherapy for head and neck malignances: what factors impact it? Nutr Cancer. 2003;47(2):136–40.

    Article  PubMed  Google Scholar 

  19. Newman L, Vieira F, Schwiezer V, et al. Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol. 1998;124(5):589–92.

    Article  CAS  Google Scholar 

  20. Paccagnella A, Morello M, Mosto MC, et al. Early nutrition intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapy. Support Care Cancer. 2009;18(7):837–45.

    Article  PubMed  Google Scholar 

  21. Corry J, Poom W, McPhee N, et al. Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo) radiation. Head Neck. 2009;31(7):867–76.

    Article  PubMed  Google Scholar 

  22. Hiroto I, Onozawa Y, Takashi K, et al. Nutrition support for head and neck squamous cell carcinoma patients treated with chemoradiotherapy: how often and how long? ISRN Oncol. 2012;2012:274–739.

    Google Scholar 

  23. Grant D, Bradley P, Pothier DD, et al. Complications following gastrostomy tube insertion in patients with head and neck cancer: a prospective multi-instituion, systematic review and meta-analysis. Clin Otolaryngol. 2009;34(2):103–12.

    Article  CAS  PubMed  Google Scholar 

  24. Pil Im J, Myung Cha J, Kim JW, et al. Proton pump inhibitor use before percutaneous endoscopic gastrostomy is associated with adverse outcomes. Gut Liver. 2014;8(3):248–53.

    Article  Google Scholar 

  25. Handa O, Yoshida N, Fujita N, et al. Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors. Inflamm Res. 2006;55(11):476–80.

    Article  CAS  PubMed  Google Scholar 

  26. Hopkins A, McDonnell C, Breslin NP, O’Morain CA, Baird AW. Omeprazole increases permeability across isolated rat gastric mucosa pre-treated with an acid secretagogue. J Pharm Pharmacol. 2002;54(3):341–7.

    Article  CAS  PubMed  Google Scholar 

  27. Lewis S, Franco S, Young G, O’Keefe SJ. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther. 1996;10(4):557–61.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Instituto Português do Oncologia de Lisboa, Rua Professor Lima Basto, 1099-023, Lisbon, Portugal

    Joana Moleiro, Sandra Faias, Catarina Fidalgo, Miguel Serrano & A. Dias Pereira

Authors
  1. Joana Moleiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sandra Faias
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Catarina Fidalgo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Miguel Serrano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Dias Pereira
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joana Moleiro.

Ethics declarations

Conflict of interest

None of the authors has any relevant conflict of interest to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moleiro, J., Faias, S., Fidalgo, C. et al. Usefulness of Prophylactic Percutaneous Gastrostomy Placement in Patients with Head and Neck Cancer Treated with Chemoradiotherapy. Dysphagia 31, 84–89 (2016). https://doi.org/10.1007/s00455-015-9661-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00455-015-9661-y

Keywords

Search

Navigation